Violet Molecular Iodine (I2)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Violet Molecular Iodine (I2), covering 2018-07-10 to 2018-07-10. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized Double-blind, Placebo Controlled, Multi-center Study to Evaluate the Safety, Tolerability and Potential Effects of the Dietary Supplement Violet™ Molecular Iodine (I2) on Breast Health in Women With Cyclic Breast Discomfort and Tenderness [NA]